O
Osler Diagnostics
Biotech & Life Sciences · Oxford, United Kingdom · Founded 2016
A ground-breaking handheld diagnostic for testing a vast range of biomarkers MoreLess
Osler Diagnostics is a healthcare technology startup that aims to revolutionize global healthcare through its innovative product, the Osler Origin®. This device offers a wide range of tests that can be used in various healthcare settings such as emergency departments, doctor's offices, and retail pharmacies. The company's unique selling proposition lies in its proprietary "lab-in-your-hand" technology, which includes the Osler HemaTap® for sample addition, microfluidic sample preparation, and electrochemical biosensing.
The technology behind Osler Origin® is the result of extensive research at Oxford University, followed by years of industrialization by Osler. The company has a robust intellectual property portfolio that protects its unique technology.
Osler Diagnostics operates in the healthcare technology market, serving healthcare providers across different settings. Its business model revolves around the sale of its Osler Origin® device and the tests it offers. The company generates revenue from the sale of these devices and tests to healthcare providers.
The team behind Osler Diagnostics is led by Co-Founder and CEO, Connor Campbell, who has a background in medical sciences and business consultancy. The commercial strategy is overseen by Chief Commercial Officer, Tom Parenteau, who brings over 25 years of experience in global marketing and sales in the healthcare sector.
Keywords: Healthcare Technology, Osler Origin®, Lab-in-your-hand Technology, Osler HemaTap®, Microfluidic Sample Preparation, Electrochemical Biosensing, Oxford University Research, Intellectual Property, Medical Testing, Healthcare Providers.
Company overview
Osler Diagnostics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Oxford, United Kingdom
- Employees
- 125
- Open positions
- None listed
- Dealroom signal
- 65.9
Valuation & funding
Osler Diagnostics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Nov 2022 | $98M | $392M | Lansdowne Partners · Braavos Investment Advisers · M&G · Oxford Science Enterprises | ↗ |
| GRANTOther financing | Apr 2022 | $792K | — | Undisclosed | — |
| GRANTOther financing | Oct 2021 | $396K | — | Undisclosed | — |
| SERIES BOther financing | Nov 2020 | $46M | $185M | Undisclosed | — |
| GRANTOther financing | Jun 2020 | $396K | — | Undisclosed | — |
| GRANTOther financing | Apr 2019 | Defence and Security Accelerator | — | ||
| SERIES AOther financing | Dec 2018 | Michael Spencer | — | ||
| SEEDOther financing | Aug 2017 | Undisclosed | — | ||
| SEEDOther financing | Jul 2016 | Oxford Technology · Bio-Rad Laboratories · Oxford Science Enterprises | — | ||
| SPINOUTOther financing | Jun 2016 | Oxford University Innovation · University of Oxford | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $368K | 0% | −$28M | -7730.3% |
| 2025 | $368K | 0% | −$28M | -7730.3% |
| 2024 | $368K | 0% | −$28M | -7730.3% |
| 2023 | $368K | 0% | −$28M | -7730.3% |
| 2022 | $368K | 0% | −$28M | -7730.3% |
| 2021 | $368K | -16.4% | −$30M | -8044% |
| 2020 | $440K | — | −$25M | -5582.7% |
Growth signals
Osler Diagnostics website traffic
Latest recorded traffic for Osler Diagnostics is 2.4K monthly website visits, up 140% over the last three months. Osler Diagnostics's team declined 15% over the past year.
Hiring
Open positions at Osler Diagnostics
Current openings linked to this company in Dealroom.
Comparisons
Osler Diagnostics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Osler Diagnostics's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on Osler Diagnostics's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Osler Diagnostics has talent and traffic
team presence
In the news
Latest news about Osler Diagnostics
Recent press, funding announcements, and product moves mentioning Osler Diagnostics — open to read from the original sources.
Market sentiment
What the market is saying about Osler Diagnostics
An AI-synthesized read of the highest-engagement posts about Osler Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Osler Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.